Blueprint Medicines Corporation (LON: 0HOJ)
London
· Delayed Price · Currency is GBP · Price in USD 112.31
-1.41 (-1.24%)
At close: Jan 31, 2025
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of 5.75 billion as of January 31, 2025. Its market cap has increased by 50.96% in one year.
Market Cap
5.75B
Enterprise Value
5.63B
Revenue
324.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
112.31
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from 317.21M to 5.75B, an increase of 1,713.04%. That is a compound annual growth rate of 34.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.89B |
| GSK plc | 57.33B |
| Haleon | 33.92B |
| Smith & Nephew | 9.00B |
| Hikma Pharmaceuticals | 5.08B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.39B |